One important goal of the Gestwicki group is to translate our findings to the benefit of human health. This 2011 interview with Dr. Gestwicki illustrates some of our efforts towards that goal. Out of the Blue Video Link
Our work on small molecules that control the assembly and disassembly of Hsp70 chaperone complexes was featured in the May 31st, 2010 issue of Chemical and Engineering News. Link
The collaborative efforts of the Gestwicki and Dickey groups on reducing tau levels as a therapeutic treatmnet for Alzheimer's disease is featured in the September 30th 2009 issue of USF Health Link, Science Codex Link, and Science Daily Link
An article on Dr. Gestwicki apeared in an almuni newsletter from the Dept. of Biochemistry at the University of Wisconsin at Madison. Link.
As a post-doctoral researcher in the lab of Howard Hughes Medical Institute (HHMI) Investigator Gerald Crabtree at Stanford University, Dr. Gestwicki conducted research that has impacted both the scientific community and general public. His most important contribution has been the development of a molecule that can block proteins which build up in neurons in the brain, causing diseases such as Alzheimer's.
ABC News - Oct. 29, 2004 - "Drug May Block Alzheimer's" (PDF)
BBC News - Oct. 29, 2004 - "Molecule Offers Alzheimer's Hope" (PDF)
CNN News - Oct. 29, 2004 - "Scientists Say Drug May Block Alzheimer's" (PDF)
Chemical & Engineering News - Nov. 1, 2004 - "How to Keep Proteins Apart" (PDF)
Howard Hughes Medical Institute News - Oct. 29, 2004 - "Trojan-Horse Therapy Blocks Buildup of Alzheimer's Plaques" (PDF)
Science News - Oct. 29, 2004 - "A Wily Recruiter in the Battle Against Toxic β Amyloid Aggregation" (PDF)
Scientific American News - Oct. 29, 2004 - "Compound Slows Key Step in Alzheimer's" (PDF)
